CareDx, Inc. (CDNA) vs Sotera Health Company (SHC)

CareDx, Inc. and Sotera Health Company are both Diagnostics & Research companies. Sotera Health Company is the larger, with a market value of $4.5B against $4.0B — 1.1× the size. Sotera Health Company trades at the lower P/E: 26.3× against 30.9×. CareDx, Inc. grew revenue faster over the last twelve months: 38.9% against 6.90%. CareDx, Inc. has the higher net margin (25.9% vs 14.1%) and the higher return on invested capital (33.6% vs 9.80%). Across the 21 metrics below, Sotera Health Company leads on 12 and CareDx, Inc. on 9.

Valuation

Metric CDNA SHC Diagnostics & Research median
P/E 30.91 26.27 34.52
P/S 8.06 3.69 4.24
P/B 8.58 6.19 3.42
Price to free cash flow 68.93 33.51 33.51
EV/EBITDA 26.62 11.86 23.44
EV/Sales 7.57 5.18 5.18
Earnings yield 3.24% 3.81% (1.50%)
Free cash flow yield 1.45% 2.98% 0.00%

Profitability

Metric CDNA SHC Diagnostics & Research median
Gross margin 70.97% 54.62% 48.32%
Operating margin 23.42% 32.66% (5.68%)
Net margin 25.86% 14.11% (4.10%)
Free cash flow margin 12.01% 11.01% 0.00%
Return on equity 33.04% 27.03% 0.00%
Return on assets 23.96% 5.28% (6.05%)
Return on invested capital 33.56% 9.80% 0.00%

Growth

Metric CDNA SHC Diagnostics & Research median
Revenue growth (TTM) 38.94% 6.90% 8.99%
EPS growth (last fiscal year) (143.01%) 68.75% 20.36%
Revenue growth, 5-year CAGR 14.59% 7.30% 7.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CDNA SHC Diagnostics & Research median
Debt to equity 0.00 3.06 0.01
Current ratio 2.31 3.13 2.27
Net debt to EBITDA 19.49 3.74 0.68

Dividend

Metric CDNA SHC Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric CDNA SHC Diagnostics & Research median
Market cap 4.01b 4.53b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack